Legal Notice
Company Identification
Company Name: CareSync SARL
Legal Form: Limited Liability Company (SARL)
Share Capital: 10,000 DHS
Registered Office: Rue ESSANAOUBAR – Building 2 – 4th Floor – Apt N°: 12 – CASABLANCA, Morocco
Year of Incorporation: 2025
Management
Manager: Mr. ZOLI, JOHAN, ARMAND
Nationality: French
Business Purpose
The company's main business activities include:
- Software Development and Artificial Intelligence
- Development and Marketing of Healthcare Solutions
- Mobile and Web Application Development
- IT services in the medical field
- Healthcare Information Technology Consulting
- IT Services and Software Development
- Healthcare business strategy consulting
Website Hosting
Website: www.caresync.wf
Email: contact@caresync.wf
Intellectual Property
The website www.caresync.wf and all of its content (texts, images, graphics, logo, icons, sounds, software, etc.) are the exclusive property of CareSync SARL, except for trademarks, logos or content belonging to other partner companies or authors.
Any reproduction, representation, modification, publication, adaptation of all or part of the site elements, whatever the means or process used, is prohibited, except with prior written authorization from CareSync SARL.
Limitation of Liability
The information contained on this site is as accurate as possible and the site is updated at different periods of the year, but may nevertheless contain inaccuracies or omissions.
If you notice a gap, error or what appears to be a malfunction, please report it by email to contact@caresync.wf, describing the problem as precisely as possible.
Applicable Law and Jurisdiction
Any dispute in connection with the use of the website www.caresync.wf is subject to Moroccan law. Exclusive jurisdiction is attributed to the competent courts of Casablanca.
Contact
For any questions regarding these legal notices, you can contact us:
- By email: contact@caresync.wf
- By mail: CareSync SARL, Rue ESSANAOUBAR – Building 2 – 4th Floor – Apt N°: 12 – CASABLANCA, Morocco
Last updated: 2025